DUPONT CAPITAL MANAGEMENT CORP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$156,000
-13.3%
2,0830.0%0.00%0.0%
Q4 2020$180,000
-71.7%
2,083
-53.7%
0.00%
-71.4%
Q3 2018$636,000
+31.4%
4,500
+49.9%
0.01%
+16.7%
Q1 2018$484,000
-2.0%
3,0020.0%0.01%
+9.1%
Q4 2017$494,000
-41.4%
3,002
-77.8%
0.01%
-42.1%
Q3 2017$843,000
-21.7%
13,5280.0%0.02%
-20.8%
Q2 2017$1,077,000
+12.1%
13,5280.0%0.02%
+14.3%
Q1 2017$961,000
+39.1%
13,5280.0%0.02%
+40.0%
Q4 2016$691,000
+10.9%
13,5280.0%0.02%
+7.1%
Q3 2016$623,00013,5280.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders